
For adults with episodic cluster headache:
Every moment without cluster headache is worth celebrating
Emgality 300 mg can help give you more cluster headache-free moments to celebrate. It's the first and only medication approved by the FDA to reduce the number of attacks.
Emgality is a prescription medicine used for the treatment of episodic cluster headache in adults.
Select Safety Information
Do not use Emgality if you are allergic to galcanezumab-gnlm or any of the ingredients in Emgality.
Hear from a real patient on Emgality 300 mg
Watch Bryan's story as he describes his journey to more cluster headache-free moments with Emgality 300 mg
Watch Patient Story
Celebrate with the Emgality savings program*
You can get Emgality for as little as $0 for up to 12 months with the Savings Card*
Governmental beneficiaries excluded, terms and conditions apply.
Requesting an Emgality Savings Card shouldn’t take more than a few minutes.
*Terms and Conditions:
Offer good for up to 12 months of Emgality from Patient qualification into the program. Patients that have commercial drug insurance coverage for Emgality may be able to pay as little as $0 for a 30-day supply of Emgality. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate annual cap of $4,900. Patients that have commercial drug insurance but do not have coverage for Emgality may be able to pay as little as $0 for their first fill of a 30-day supply of Emgality. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. This offer is invalid for Patients without commercial drug insurance or whose prescription claims for Emgality are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any State Patient or Pharmaceutical Assistance Program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation is required. Subject to additional terms and conditions, which can be found
here.
TRICARE® is a registered trademark of the Department of Defense (DoD), DHA.
Finally, a medication approved for the treatment of episodic cluster headache that reduces the number of attacks

Emgality 300 mg cut weekly cluster headache attacks in half or more for a majority of people. 71% of people had their weekly attacks cut in half or more vs 53% of people taking placebo at Week 3.
Over the first three weeks of taking Emgality, people in a study had an average of 9 fewer attacks each week vs 5 fewer weekly attacks for people taking placebo.
Emgality 300 mg can help reduce the number of weekly cluster headache attacks so you can have more moments without cluster headache pain. Discover more about Emgality 300 mg.
Learn about Emgality